According to ImmunityBio's latest financial reports the company has a price-to-book ratio of -8.53.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2023-12-31 | -5.72 | 26.79% |
2022-12-31 | -4.51 | -54.5% |
2021-12-31 | -9.92 | |
2020-12-31 | N/A |
Company | P/B ratio | differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | 2.43 | -128.47% | ๐บ๐ธ USA |